InvestSMART

Resonance Health Limited (ASX: RHT) - Announcements

- Current share price for RHT : $0.083

ASX company news and announcements for Resonance Health Limited (RHT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Resonance Health Limited (RHT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Resonance Health Limited (RHT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Resonance Health Limited (RHT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$40 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2022 8:23AM $0.160 $0.083 fallen by 48.13%
$40 Resonance Health Enters China - Pharma Contract Signed 27 Jan 2022 2:37PM $0.160 $0.083 fallen by 48.13%
$40 Resonance Health Contracted for Third Party Clinical Trial 25 Jan 2022 8:22AM $0.155 $0.083 fallen by 46.45%
$40 Change in substantial holding 18 Jan 2022 12:23PM $0.190 $0.083 fallen by 56.32%
$40 US FDA Clearance for LiverSmart 30 Dec 2021 10:04AM $0.110 $0.083 fallen by 24.55%
$40 ASO Project New Data 20 Dec 2021 10:04AM $0.100 $0.083 fallen by 17%
$40 LiverSmart Submitted to FDA for US Regulatory Clearance 3 Dec 2021 9:22AM $0.105 $0.083 fallen by 20.95%
$40 Jobkeeper Announcement 29 Nov 2021 8:26AM $0.110 $0.083 fallen by 24.55%
$40 Results of Meeting 25 Nov 2021 3:08PM $0.120 $0.083 fallen by 30.83%
$40 Investor Presentation - Positioning for Growth 25 Nov 2021 12:01PM $0.118 $0.083 fallen by 29.36%
$40 Appointment of CMO - Professor John Olynyk 24 Nov 2021 8:13AM $0.110 $0.083 fallen by 24.55%
$40 ASO R&D Project - Filing of Two Patent Applications 23 Nov 2021 8:21AM $0.100 $0.083 fallen by 17%
$40 Thalassaemia International Federation to Deploy FerriSmart 12 Nov 2021 8:24AM $0.100 $0.083 fallen by 17%
$40 Quarterly Activities/Appendix 4C Cash Flow Report 29 Oct 2021 8:09AM $0.105 $0.083 fallen by 20.95%
$40 Notice of Annual General Meeting/Proxy Form 25 Oct 2021 8:10AM $0.115 $0.083 fallen by 27.83%
$40 Sales & Marketing Update 14 Oct 2021 8:22AM $0.095 $0.083 fallen by 12.63%
$40 New AI Medical Device 13 Oct 2021 8:20AM $0.087 $0.083 fallen by 4.60%
$40 AGM Date and Director Nomination Closing Date 7 Oct 2021 8:22AM $0.087 $0.083 fallen by 4.60%
$40 Appendix 4G and Corporate Governance Statement 30 Sep 2021 8:02AM $0.097 $0.083 fallen by 14.43%
$40 Annual Report to shareholders 30 Sep 2021 8:01AM $0.097 $0.083 fallen by 14.43%
$40 Change in substantial holding 28 Sep 2021 2:19PM $0.100 $0.083 fallen by 17%
$40 R&D Molecular Medicine ASON Project Results of Dosing Study 21 Sep 2021 3:23PM $0.100 $0.083 fallen by 17%
$40 Preliminary Final Report 30 Aug 2021 8:12AM $0.120 $0.083 fallen by 30.83%
$40 Quarterly Activities/Appendix 4C Cash Flow Report 2 Aug 2021 8:09AM $0.165 $0.083 fallen by 49.70%
$40 Appointment of GM - Global Sales & Marketing 28 Jul 2021 8:20AM $0.150 $0.083 fallen by 44.67%

151 - 175 of 534 results

Page 7 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.